MetLife Investment Management’s Escalade ESCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$103K Buy
+6,018
New +$90.9K ﹤0.01% 2527
2025
Q3
Sell
-5,900
Closed -$82.5K 2866
2025
Q2
$82.5K Hold
5,900
﹤0.01% 2636
2025
Q1
$90.3K Hold
5,900
﹤0.01% 2572
2024
Q4
$84.3K Hold
5,900
﹤0.01% 2681
2024
Q3
$83K Hold
5,900
﹤0.01% 2690
2024
Q2
$81.4K Buy
5,900
+554
+10% +$7.42K ﹤0.01% 2679
2024
Q1
$73.5K Hold
5,346
﹤0.01% 2657
2023
Q4
$107K Hold
5,346
﹤0.01% 2581
2023
Q3
$81.8K Hold
5,346
﹤0.01% 2680
2023
Q2
$71.4K Buy
+5,346
New +$72.7K ﹤0.01% 2842

Other funds holding ESCA

MetLife Investment Management's ESCA Position: Q1 2026 in Review

MetLife Investment Management opened a new position in Escalade (ESCA) in Q1 2026: 6,018 shares worth $103K. The stake represents ﹤0.01% of the portfolio and ranks #2527 among its holdings. This is a return to the name: MetLife Investment Management previously reported a position in ESCA as recently as Q2 2025.

MetLife Investment Management first reported a position in ESCA in Q2 2023 and has held it in 10 quarters since. The position peaked at $107K in Q4 2023. 84 funds tracked by Wall St. Rank hold ESCA as of Q1 2026.

  • MetLife Investment Management held 6,018 shares of Escalade worth $103K as of Q1 2026.
  • Escalade was a new MetLife Investment Management position in Q1 2026.
  • Escalade made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2527 holding.
  • MetLife Investment Management first reported a position in Escalade in Q2 2023 and has held it in 10 quarters since.
  • MetLife Investment Management's Escalade position peaked at $107K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Escalade as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.